Selected research
Market Structure
Global DNA Gyrase Subunit B (EC 5.99.1.3) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global DNA Gyrase Subunit B (EC 5.99.1.3) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for DNA Gyrase Subunit B (EC 5.99.1.3) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for DNA Gyrase Subunit B (EC 5.99.1.3) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for DNA Gyrase Subunit B (EC 5.99.1.3) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for DNA Gyrase Subunit B (EC 5.99.1.3) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of DNA Gyrase Subunit B (EC 5.99.1.3) include Merck & Co., Inc., AstraZeneca Plc, Daiichi Sankyo Company Ltd and Abgentis Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global DNA Gyrase Subunit B (EC 5.99.1.3) market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of DNA Gyrase Subunit B (EC 5.99.1.3) and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents DNA Gyrase Subunit B (EC 5.99.1.3) revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the DNA Gyrase Subunit B (EC 5.99.1.3) market size, projected growth trends, production technologies, key applications, and end-use industries.
DNA Gyrase Subunit B (EC 5.99.1.3) Segment by Company
Merck & Co., Inc.
AstraZeneca Plc
Daiichi Sankyo Company Ltd
Abgentis Limited
DNA Gyrase Subunit B (EC 5.99.1.3) Segment by Type
VXC-100
VT-12008911
GYR-12
DS-2969
Others
DNA Gyrase Subunit B (EC 5.99.1.3) Segment by Application
Bacterial Infections
Clostridium Diffclie Infections
Klebsiella Pneumoniae Infections
Others
DNA Gyrase Subunit B (EC 5.99.1.3) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Gyrase Subunit B (EC 5.99.1.3) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA Gyrase Subunit B (EC 5.99.1.3) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Gyrase Subunit B (EC 5.99.1.3).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of DNA Gyrase Subunit B (EC 5.99.1.3) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global DNA Gyrase Subunit B (EC 5.99.1.3) industry.
Chapter 3: Detailed analysis of DNA Gyrase Subunit B (EC 5.99.1.3) companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, DNA Gyrase Subunit B (EC 5.99.1.3)revenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- VXC-100
- VT-12008911
- GYR-12
- DS-2969
- Others
Applications
- Bacterial Infections
- Clostridium Diffclie Infections
- Klebsiella Pneumoniae Infections
- Others
Companies covered
- Merck & Co., Inc.
- AstraZeneca Plc
- Daiichi Sankyo Company Ltd
- Abgentis Limited
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 VXC-100
- 1.2.3 VT-12008911
- 1.2.4 GYR-12
- 1.2.5 DS-2969
- 1.2.6 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Bacterial Infections
- 1.3.3 Clostridium Diffclie Infections
- 1.3.4 Klebsiella Pneumoniae Infections
- 1.3.5 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global DNA Gyrase Subunit B (EC 5.99.1.3) Growth Trends by Region
- 1.5.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region (2021-2026)
- 1.5.3 DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Dynamics
- 2.1 DNA Gyrase Subunit B (EC 5.99.1.3) Industry Trends
- 2.2 DNA Gyrase Subunit B (EC 5.99.1.3) Industry Drivers
- 2.3 DNA Gyrase Subunit B (EC 5.99.1.3) Industry Opportunities and Challenges
- 2.4 DNA Gyrase Subunit B (EC 5.99.1.3) Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Revenue by Company (2021-2026)
- 3.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global DNA Gyrase Subunit B (EC 5.99.1.3) Key Company Head office and Area Served
- 3.4 Global DNA Gyrase Subunit B (EC 5.99.1.3) Company, Product Type & Application
- 3.5 Global DNA Gyrase Subunit B (EC 5.99.1.3) Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 DNA Gyrase Subunit B (EC 5.99.1.3) Players Market Share by Revenue in 2025
- 3.6.3 2025 DNA Gyrase Subunit B (EC 5.99.1.3) Tier 1, Tier 2, and Tier 3
4 DNA Gyrase Subunit B (EC 5.99.1.3) Market by Type
- 4.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2021-2032)
- 4.3 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Share by Type (2021-2032)
5 DNA Gyrase Subunit B (EC 5.99.1.3) Market by Application
- 5.1 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2021-2032)
- 5.3 Global DNA Gyrase Subunit B (EC 5.99.1.3) Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Merck & Co., Inc.
- 6.1.1 Merck & Co., Inc. Company Information
- 6.1.2 Merck & Co., Inc. Business Overview
- 6.1.3 Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Merck & Co., Inc. DNA Gyrase Subunit B (EC 5.99.1.3) Product Portfolio
- 6.1.5 Merck & Co., Inc. Recent Developments
- 6.2 AstraZeneca Plc
- 6.2.1 AstraZeneca Plc Company Information
- 6.2.2 AstraZeneca Plc Business Overview
- 6.2.3 AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 AstraZeneca Plc DNA Gyrase Subunit B (EC 5.99.1.3) Product Portfolio
- 6.2.5 AstraZeneca Plc Recent Developments
- 6.3 Daiichi Sankyo Company Ltd
- 6.3.1 Daiichi Sankyo Company Ltd Company Information
- 6.3.2 Daiichi Sankyo Company Ltd Business Overview
- 6.3.3 Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Daiichi Sankyo Company Ltd DNA Gyrase Subunit B (EC 5.99.1.3) Product Portfolio
- 6.3.5 Daiichi Sankyo Company Ltd Recent Developments
- 6.4 Abgentis Limited
- 6.4.1 Abgentis Limited Company Information
- 6.4.2 Abgentis Limited Business Overview
- 6.4.3 Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Abgentis Limited DNA Gyrase Subunit B (EC 5.99.1.3) Product Portfolio
- 6.4.5 Abgentis Limited Recent Developments
7 North America
- 7.1 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (2021-2032)
- 7.2 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type
- 7.2.1 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2021-2026)
- 7.2.2 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2027-2032)
- 7.2.3 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Type (2021-2032)
- 7.3 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application
- 7.3.1 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2021-2026)
- 7.3.2 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2027-2032)
- 7.3.3 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Application (2021-2032)
- 7.4 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country
- 7.4.1 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2021-2026)
- 7.4.3 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2027-2032)
- 7.4.4 North America DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (2021-2032)
- 8.2 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type
- 8.2.1 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2021-2026)
- 8.2.2 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2027-2032)
- 8.2.3 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Type (2021-2032)
- 8.3 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application
- 8.3.1 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2021-2026)
- 8.3.2 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2027-2032)
- 8.3.3 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Application (2021-2032)
- 8.4 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country
- 8.4.1 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2021-2026)
- 8.4.3 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2027-2032)
- 8.4.4 Europe DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (2021-2032)
- 9.2 China DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type
- 9.2.1 China DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2021-2026)
- 9.2.2 China DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2027-2032)
- 9.2.3 China DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Type (2021-2032)
- 9.3 China DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application
- 9.3.1 China DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2021-2026)
- 9.3.2 China DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2027-2032)
- 9.3.3 China DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (2021-2032)
- 10.2 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type
- 10.2.1 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2021-2026)
- 10.2.2 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2027-2032)
- 10.2.3 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Type (2021-2032)
- 10.3 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application
- 10.3.1 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2021-2026)
- 10.3.2 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2027-2032)
- 10.3.3 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Application (2021-2032)
- 10.4 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country
- 10.4.1 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2021-2026)
- 10.4.3 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2027-2032)
- 10.4.4 Asia DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size (2021-2032)
- 11.2 South America, Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type
- 11.2.1 South America, Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application
- 11.3.1 South America, Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country
- 11.4.1 South America, Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa DNA Gyrase Subunit B (EC 5.99.1.3) Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst